Bladder cancer – the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register clinicaltrials.gov
Open Access
- 24 October 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Urology
- Vol. 13 (1), 56
- https://doi.org/10.1186/1471-2490-13-56
Abstract
Uro-oncological neoplasms have both a high incidence and mortality rate and are therefore a major public health problem. The aim of this study was to evaluate research activity in uro-oncology over the last decade. We searched MEDLINE and ClinicalTrials.gov systematically for studies on prostatic, urinary bladder, kidney, and testicular neoplasms. The increase in newly published reports per year was analyzed using linear regression. The results are presented with 95% confidence intervals, and a p value <0.05 was considered statistically significant. The number of new publications per year increased significantly for prostatic, kidney and urinary bladder neoplasms (all <0.0001). We identified 1,885 randomized controlled trials (RCTs); also for RCTs, the number of newly published reports increased significantly for prostatic (p = 0.001) and kidney cancer (p = 0.005), but not for bladder (p = 0.09) or testicular (p = 0.44) neoplasms. We identified 3,114 registered uro-oncological studies in ClinicalTrials.gov. However, 85% of these studies are focusing on prostatic (45%) and kidney neoplasms (40%), whereas only 11% were registered for bladder cancers. While the number of publications on uro-oncologic research rises yearly for prostatic and kidney neoplasms, urothelial carcinomas of the bladder seem to be neglected despite their important clinical role. Clinical research on neoplasms of the urothelial bladder must be explicitly addressed and supported.Keywords
This publication has 20 references indexed in Scilit:
- Demographic analysis of randomized controlled trials in bladder cancerBJU International, 2012
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2012
- Hot topics in urological health economics. A mini review.2012
- Do urology journals enforce trial registration? A cross-sectional study of published trialsBMJ Open, 2011
- Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU GuidelinesEuropean Urology, 2011
- EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 UpdateEuropean Urology, 2011
- Does the biomarker search paradigm need re-booting?BMC Urology, 2009
- Publication bias in clinical trials due to statistical significance or direction of trial resultsCochrane Database of Systematic Reviews, 2009
- How to Perform a Literature SearchJournal of Urology, 2008
- Microsatellite instability as prognostic marker in bladder tumors: a clinical significanceBMC Urology, 2005